Differences in the apparent metabolic clearance rate of testosterone in young and older men with gonadotropin suppression receiving graded doses of testosterone

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 11, 2006, Pages 4669-4675

  Coviello, Andrea D ^a   Lakshman, Kishore ^b   Mazer, Norman A ^a   Bhasin, Shalender ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; GONADORELIN AGONIST; GONADOTROPIN; LEUPRORELIN; TESTOSTERONE; TESTOSTERONE ENANTATE;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DOSE REGIMEN; HORMONE DETERMINATION; HORMONE SYNTHESIS; HUMAN; HUMAN EXPERIMENT; LEAN BODY WEIGHT; MALE; METABOLIC CLEARANCE RATE; MULTIPLE REGRESSION; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

EID: 33751529229     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0822     Document Type: Article

References (32)

1. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB 2002 Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87:589-598
2. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR 2001 Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724-731
3. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Synder PJ, Swerdloff RS, Moutori VM 2006 Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 91:1995-2010
4. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG 2001 Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 56:M266-M272
5. Sih R, Morley JE, Kaiser FE, Perry 3 rd HM, Patrick P, Ross C 1997 Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82:1661-1667
6. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad Jr JG, Strom BL 1999 Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 84:1966-1972
7. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL 1999 Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84:2647-2653
8. Tenover JS 1992 Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 75:1092-1098
9. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE 2003 Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci 58:618-625
10. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL 2005 Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90:1502-1510
11. Bhasin S, Buckwalter JG 2001 Testosterone supplementation in older men: a rational idea whose time has not yet come. J Androl 22:718-731
12. Liverman CT, Blazer DG 2004 Testosterone and aging: clinical research directions. In: Press NA, ed. Washington, DC: Institute of Medicine
13. Rhoden EL, Morgentaler A 2004 Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 350:482-492
14. Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S 2005 Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 60:1451-1457
15. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu FC 2005 Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol 48:1-4
16. Bhasin S, Singh AB, Mac RP, Carter B, Lee MI, Cunningham GR 2003 Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. J Androl 24: 299-311
17. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Mac RP, Lee M, Yarasheski KE, Sinha-Hikim I, Dzekov C, Dzekov J, Magliano L, Storer TW 2005 Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 90:678-688
18. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N, Chen X, Yarasheski KE, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R, Storer TW 2001 Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281:E1172-E1181
19. Gibaldi M, Perrier D 1982 Pharmacokinetics, Second Edition. New York: Marcel Dekker, Inc.
20. Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE, Mazer NA 1999 Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 84:3469-3478
21. Meikle AW, Arver S, Dobs AS, Sanders SW, Rajaram L, Mazer NA 1996 Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site - a clinical research center study. J Clin Endocrinol Metab 81:1832-1840
22. Choi HH, Gray PB, Storer TW, Calof OM, Woodhouse L, Singh AB, Padero C, Mac RP, Sinha-Hikim I, Shen R, Dzekov J, Dzekov C, Kushnir MM, Rockwood AL, Meikle AW, Lee ML, Hays RD, Bhasin S 2005 Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss. J Clin Endocrinol Metab 90:1531-1541
23. Morimoto I, Edmiston A, Hawks D, Horton R 1981 Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men. J Clin Endocrinol Metab 52:772-778
24. Wang C, Catlin DH, Starcevic B, Leung A, DiStefano E, Lucas G, Hull L, Swerdloff RS 2004 Testosterone metabolic clearance and production rates determined by stable isotope dilution/tandem mass spectrometry in normal men: influence of ethnicity and age. J Clin Endocrinol Metab 89:2936-2941
25. Ishimaru T, Edmiston WA, Pages L, Horton R 1978 Splanchnic extraction and conversion of testosterone and dihydrotestosterone in man. J Clin Endocrinol Metab 46:528-533
26. Baird DT, Horton R, Longcope C, Tait JF 1969 Steroid dynamics under steady-state conditions. Recent Prog Horm Res 25:611-664
27. Zoli M, Magalotti D, Bianchi G, Gueli C, Orlandini C, Grimaldi M, Marchesini G 1999 Total and functional hepatic blood flow decrease in parallel with ageing. Age Ageing 28:29-33
28. Ishimaru T, Edminston A, Pages L, Horton R 1978 The extrasplanchnic origin of blood dihydrotestosterone in elderly men. Steroids 31:439-451
29. Muller M, Grobbee DE, den Tonkelaar I, Lamberts SW, van der Schouw YT 2005 Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 90:2618-2623
30. Denti L, Pasolini G, Sanfelici L, Benedetti R, Cecchetti A, Ceda GP, Ablondi F, Valenti G 2000 Aging-related decline of gonadal function in healthy men: correlation with body composition and lipoproteins. J Am Geriatr Soc 48:51-58
31. Gapstur SM, Gann PH, Kopp P, Colangelo L, Longcope C, Liu K 2002 Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 11:1041-1047
32. Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE, van der Schouw YT 2003 Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol 149:583-589